References
Vély, F. et al. Nat. Immunol. 17, 1291–1299 (2016).
Weinkove, R., Filbey, K. & Le Gros, G. Nat. Immunol. 17, 1237–1238 (2016).
Mace, E. M. & Orange, J. S. Front. Immunol. 7, 545 (2016).
Mace, E. M. et al. J. Clin. Immunol. 37, 1–74 (2017).
Fehniger, T. A., Cooper, M. A. & Harnessing, N. K. Trends Immunol. 37, 877–888 (2016).
Malmberg, K. J. et al. Semin. Immunol. 31, 20–29 (2017).
Holmes, T. D. & Bryceson, Y. T. Semin. Immunol. 28, 368–376 (2016).
Khakoo, S. I. et al. Science 305, 872–874 (2004).
Martin, M. P. & Carrington, M. Immunol. Rev. 254, 245–264 (2013).
Imai, K., Matsuyama, S., Miyake, S., Suga, K. & Nakachi, K. Lancet 356, 1795–1799 (2000).
Kamili, Q. U. A. et al. J. Allergy Clin. Immunol. 134, 1451–1453 (2014).
Laffort, C. et al. Lancet 363, 2051–2054 (2004).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
T.A.F. is a member of the scientific advisory board for Cyto-Sen Therapeutics and receives research funding from Celgene, Affimed and Altor BioScience.
Rights and permissions
About this article
Cite this article
Orange, J.S., Mace, E.M., French, A.R. et al. Comment on: Evidence of innate lymphoid cell redundancy in humans. Nat Immunol 19, 788–789 (2018). https://doi.org/10.1038/s41590-018-0164-5
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41590-018-0164-5
- Springer Nature America, Inc.
This article is cited by
-
Non-redundant functions of group 2 innate lymphoid cells
Nature (2022)
-
How I Manage Natural Killer Cell Deficiency
Journal of Clinical Immunology (2020)
-
Reply to ‘Comment on: Evidence of innate lymphoid cell redundancy in humans’
Nature Immunology (2018)